Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03110614 · ClinicalTrials.gov registry record
Diastolic Dysfunction and Pauci-inflammatory Acute Exacerbations of COPD
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 94
- Enrollment target
NCT03110614: Completed study, sponsored by University of Alabama at Birmingham.
NCT03110614 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 94 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03110614 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 94 participants
- Enrollment target
Study Summary
This is a prospective study to determine the relationships between pauci-inflammatory exacerbations and diastolic dysfunction, and their implications in hospitalized patients with acute exacerbations of COPD. To assess changes within subjects from stable to acute phase, a number of comparisons will be made in subjects enrolled during acute exacerbation with similar measurements made in the stable phase after recovery from exacerbation after at least 35 days from index hospitalization or prior exacerbation.
Primary Outcome
We will estimate the frequency of diastolic dysfunction on echocardiogram in exacerbations that are pauci-inflammatory vs. inflammatory at the time of enrollment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2013-11-25 |
| Est. Completion | 2021-08-30 |
What the finished NCT03110614 record still lists
NCT03110614 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 94 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03110614 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03110614 about?
NCT03110614 is a clinical study titled "Diastolic Dysfunction and Pauci-inflammatory Acute Exacerbations of COPD". This is a prospective study to determine the relationships between pauci-inflammatory exacerbations and diastolic dysfunction, and their implications in hospitalized patients with acute exacerbations of COPD. To assess changes within subjects from stable to acute phase, a number of comparisons will ...
What is the current status of trial NCT03110614?
This trial is currently completed. The enrollment target is 94 participants. The study started on 2013-11-25. Estimated completion is 2021-08-30.
Who is sponsoring clinical trial NCT03110614?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03747146 · 94 participants · NA
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
- NCT04061421 · 94 participants · Phase 1
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
- NCT04205968 · 94 participants · Phase 2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
- NCT04464759 · 94 participants · Phase 1
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI